NYSE:IVR.C Invesco Mortgage Capital (IVR.C) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free IVR.C Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range$19.00▼$22.7052-Week Range N/AVolume18,475 shsAverage Volume13,859 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Invesco Mortgage Capital alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> IVR.C Stock News HeadlinesApril 10, 2024 | msn.comWant $6,000 In Passive Income? Invest $3,000 Into These 12 Dividend StocksApril 1, 2024 | msn.comBeat High Mortgage Rates With an Intrafamily Loan. Here’s How the Taxes Work.April 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.March 20, 2024 | finance.yahoo.comIVR Mar 2024 11.500 callMarch 19, 2024 | finance.yahoo.comIVR Jul 2024 6.000 callMarch 15, 2024 | finance.yahoo.comIVR Mar 2024 13.000 callMarch 6, 2024 | finance.yahoo.comIVR Mar 2024 12.500 callFebruary 24, 2024 | au.investing.comEarnings call: Invesco Mortgage Capital reports stable Q4 with modest gainsApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.February 16, 2024 | ca.finance.yahoo.comIVR Mar 2024 7.500 callFebruary 16, 2024 | finance.yahoo.comIVR Feb 2024 8.000 callFebruary 13, 2024 | wsj.comInvesco Mortgage Capital Inc. 7.5% Cum. Redeem. Pfd. Series CFebruary 8, 2024 | msn.comInvesco Mortgage Capital (IVR) Stock Drops Despite Market Gains: Important Facts to NoteJanuary 23, 2024 | wsj.comInvesco Mortgage Capital Inc.January 15, 2024 | seekingalpha.comInvesco Mortgage Capital To Benefit From Fed ShiftDecember 7, 2023 | msn.comUBS Initiates Coverage of Invesco Mortgage Capital (IVR) with Neutral RecommendationNovember 8, 2023 | finance.yahoo.comInvesco Mortgage Capital Inc. (NYSE:IVR) Q3 2023 Earnings Call TranscriptNovember 3, 2023 | benzinga.comEarnings Outlook For Invesco Mortgage CapitalOctober 30, 2023 | finance.yahoo.comInvesco Mortgage Capital Inc. To Announce Third Quarter 2023 ResultsOctober 20, 2023 | msn.comBTIG Initiates Coverage of Invesco Mortgage Capital (IVR) with Neutral RecommendationOctober 19, 2023 | msn.comInvesco Mortgage Capital: Strong Bearish Trend Shows No Sign Of A ReversalOctober 17, 2023 | msn.comHere's Why Invesco Mortgage Capital (IVR) Fell More Than Broader MarketOctober 11, 2023 | msn.comWhy Invesco Mortgage Capital (IVR) Outpaced the Stock Market TodayAugust 3, 2023 | finance.yahoo.comInvesco Mortgage Capital Inc. Reports Second Quarter 2023 Financial ResultsJuly 24, 2023 | finance.yahoo.comInvesco Mortgage Capital Inc. To Announce Second Quarter 2023 ResultsMay 11, 2023 | msn.comRecap: Invesco Mortgage Capital Q1 EarningsMay 10, 2023 | marketwatch.comInvesco Mortgage Capital Inc. stock rises Wednesday, outperforms marketSee More Headlines Receive IVR.C Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invesco Mortgage Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:IVR.C CUSIPN/A CIKN/A WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:IVR.C) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Mortgage Capital Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.